{"id":269,"date":"2014-10-30T20:22:04","date_gmt":"2014-10-30T20:22:04","guid":{"rendered":"http:\/\/www.euroespa.com\/?page_id=269"},"modified":"2014-11-19T09:06:01","modified_gmt":"2014-11-19T09:06:01","slug":"malignant-hyperthermia","status":"publish","type":"page","link":"https:\/\/www.euroespa.com\/science-education\/specialized-sections\/espa-guidelines\/emergency-care\/malignant-hyperthermia\/","title":{"rendered":"Malignant hyperthermia"},"content":{"rendered":"<p><strong>Management of Malignant Hyperthermia crisis<\/strong><\/p>\n<p>Below are links to information relating to the management of patients develop Malignant Hyperthermia.<\/p>\n<ul>\n<li><a href=\"http:\/\/www.aagbi.org\/sites\/default\/files\/MH%20guideline%20for%20web%20v2.pdf\">http:\/\/www.aagbi.org\/sites\/default\/files\/MH%20guideline%20for%20web%20v2.pdf<\/a><\/li>\n<li><a href=\"http:\/\/www.aagbi.org\/sites\/default\/files\/MH%20recommended%20contents%20for%20web.pdf\">http:\/\/www.aagbi.org\/sites\/default\/files\/MH%20recommended%20contents%20for%20web.pdf<\/a><\/li>\n<li><a href=\"http:\/\/www.aagbi.org\/sites\/default\/files\/MH%20task%20allocations%20for%20web.pdf\">http:\/\/www.aagbi.org\/sites\/default\/files\/MH%20task%20allocations%20for%20web.pdf<\/a><\/li>\n<\/ul>\n<p>Below an example of the ESPA Action Card for the management of Malignant Hyperthermia:<\/p>\n<p><a href=\"http:\/\/www.euroespa.com\/wp-content\/uploads\/2014\/10\/gMH_Page_1small.jpg\" rel=\"lightbox\" data-width=\"543\" data-height=\"768\"><img decoding=\"async\" src=\"http:\/\/www.euroespa.com\/content\/uploads\/2014\/10\/gMH_Page_1small.jpg\" alt=\"\" class=\"aligncenter\" \/><\/a><\/p>\n<p><a href=\"http:\/\/www.euroespa.com\/wp-content\/uploads\/2014\/10\/gMH_Page_2small.jpg\" rel=\"lightbox\" data-width=\"543\" data-height=\"768\"><img decoding=\"async\" src=\"http:\/\/www.euroespa.com\/content\/uploads\/2014\/10\/gMH_Page_2small.jpg\" alt=\"\" class=\"aligncenter\" \/><\/a><\/p>\n<p><a href=\"http:\/\/www.euroespa.com\/wp-content\/uploads\/2014\/10\/gMH_Page_3small.jpg\" rel=\"lightbox\" data-width=\"500\" data-height=\"707\"><img decoding=\"async\" src=\"http:\/\/www.euroespa.com\/content\/uploads\/2014\/10\/gMH_Page_3small.jpg\" alt=\"\" class=\"aligncenter\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Management of Malignant Hyperthermia crisis Below are links to information relating to the management of patients develop Malignant Hyperthermia. http:\/\/www.aagbi.org\/sites\/default\/files\/MH%20guideline%20for%20web%20v2.pdf&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":264,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_searchwp_excluded":"","footnotes":""},"class_list":["post-269","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.euroespa.com\/api\/wp\/v2\/pages\/269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euroespa.com\/api\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.euroespa.com\/api\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.euroespa.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euroespa.com\/api\/wp\/v2\/comments?post=269"}],"version-history":[{"count":1,"href":"https:\/\/www.euroespa.com\/api\/wp\/v2\/pages\/269\/revisions"}],"predecessor-version":[{"id":671,"href":"https:\/\/www.euroespa.com\/api\/wp\/v2\/pages\/269\/revisions\/671"}],"up":[{"embeddable":true,"href":"https:\/\/www.euroespa.com\/api\/wp\/v2\/pages\/264"}],"wp:attachment":[{"href":"https:\/\/www.euroespa.com\/api\/wp\/v2\/media?parent=269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}